Name | R079 |
---|
Description | R079 (compound 17) is a selective, orally active Nrf2 activator. R079 increases Nrf2 translocation activity (EC50 = 32.41 μM). R079 can neutralize excess levels of reactive oxygen species through activating Nrf2. R079 has anti-inflammatory properties and can be used in multiple sclerosis research [1]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C11H11N3O3S |
---|---|
Molecular Weight | 265.29 |